Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Pleural Effusion, Malignant 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mesothelioma, Malignant 1Leukemia, Myeloid, Chronic-Phase 1Glioblastoma 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Interventions

Psilocybin 3Music Therapy 3Therapeutics 2Transcranial Direct Current Stimulation 1Surveys and Questionnaires 1Relaxation Therapy 1Referral and Consultation 1Psychotherapy 1Psychosocial Intervention 1Pharmaceutical Preparations 1Paramedics 1Palliative Care 1Niacin 1Mindfulness 1Methods 1Meditation 1Massage 1Ketamine 1Interviews as Topic 1Injections 1Fluoxetine 1Exercise Test 1Electroacupuncture 1Early Intervention, Educational 1Early Detection of Cancer 1Counseling 1Cognitive Behavioral Therapy 1Artificial Intelligence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Pharmaceutical Preparations × 90 days × Clear all
NCT07174947 2026-03-24

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Recruiting
240 enrolled

Anxiety Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡